William R. Gillespie, Ph.D.

Fellow I

For over 20 years Bill has been involved in the development and application of pharmacometric methodology for enhancing drug treatment, development and regulation. His current interests include the use of Bayesian modeling and simulation to optimize decision-making in clinical drug development and treatment. He plans to make Bayesian modeling and simulation methods more accessible via training programs and development of software tools.

Recent publications by this scientist

A Torsten case study: Evaluating the benefits of cross-chain communication during the warmup phase of Hamiltonian Monte Carlo (HMC) simulation

February 7, 2022

Yi Zhang and William R. Gillespie. Poster presented at 2021 American Conference on Pharmacometrics (ACoP12) virtual meeting. 8-12 November 2021. Poster PIIIB-028

Download PDF

I’m a Bayesian and I’m OK: Or How I Learned to Stop Worrying and Love Variability and Uncertainty

February 4, 2022

William R. Gillespie. The Lewis B. Sheiner Lecturer Award slides presented at International Society of Pharmacometrics. November 2021.

Download PDF

Torsten: Stan functions for pharmacometric applications – Improvements and new R interface workflow

September 3, 2021

Yi Zhang and William R. Gillespie.  Poster presented at Population Approach Group Europe Annual Meeting; 2-3 and 6-7 September 2021.  Poster I-61.

Download PDF